Sufentanil Citrate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Sufentanil Citrate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on May 3, 2022. Reported reason: Other

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
17478-050-02
Dosage Form
Injection
Presentation
Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02)
Initial Posting
May 3, 2022

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.